ATyr Pharma to Present at Upcoming Investor Conferences

GlobeNewswireOct 31 20:00

With 64% Ownership in ATyr Pharma, Inc. (NASDAQ:ATYR), Institutional Investors Have a Lot Riding on the Business

Simply Wall StOct 16 21:08

Express News | Point72 Asset Management, L.p. Reports 6.2% Passive Stake in aTyr Pharma as of Oct 14 - SEC Filing

BreakingsOct 16 05:04

ATyr Pharma's Lead Therapeutic Candidate Efzofitimod For Pulmonary Sarcoidosis To Be Featured In Best Of CHEST Journals At CHEST 2024 Annual Meeting October 6 – 9, 2024

BenzingaOct 8 20:10

Analysts Offer Insights on Healthcare Companies: Sandoz Group Ltd (OtherSDZXF) and ATyr Pharma (ATYR)

TipRanksOct 6 23:00 · Ratings

ATyr Pharma ATYR Phase 1b/2a Data; Summit SMMT Enrollment Completed

BioPharmCatalystOct 4 20:11